| News for nurse practitioners
|  |
- Stroke increasingly affects younger patients, study finds
The rate of strokes among adults ages 20 to 54 rose nearly twofold between 1993 and 2005, according to a study of almost 5,900 first-time stroke patients in Ohio and Kentucky. The rate increased from 26 to 48 for every 100,000 people for whites, and from 83 to 128 for every 100,000 people for blacks. The study was published in the journal Neurology. Reuters
(10/10)      
- CDC: U.S. mortality rates dropped slightly in 2011
The mortality rates for five out of the 15 main causes of death in the U.S. fell significantly from 2010 to 2011, but the average life expectancy remained at 78.7 years, according to a new CDC report. The rate of deaths from heart disease and cancer, which make up 47% of all U.S. deaths, dropped by 3% and 2.4%, respectively. The mortality rates declined for both men and women. WebMD
(10/10)
- Diabetic foot ulcers linked to increased risk of death
British researchers examined data from eight studies of diabetic patients and found that 34% of those with diabetic foot ulceration died during follow-up, compared to 17% without the complication. The study, published in the journal Diabetologia, also found a higher risk of fatal heart attacks and strokes among DFU patients. The Independent (London)
(10/10)
- Hormone therapy can help reduce cardiovascular risks, research finds
Taking hormone replacement therapy during menopause lowered the risk of heart failure and heart attacks, according to Danish researchers reporting in the journal BMJ. The 2,016-woman study found that continuous hormone therapy was not linked to increased risk of thromboembolic episodes or cancer. MedPage Today (free registration)
(10/9)
- Prenatal fish intake, mercury exposure may affect risk of ADHD
Maternal consumption of at least two fish servings a week was linked to a 60% lower risk of their children developing some attention-deficit/hyperactivity disorder symptoms, according to a study in the Archives of Pediatrics & Adolescent Medicine. However, higher mercury hair levels from mothers taken after delivery was associated with about a 60% greater likelihood of hyperactivity, inattentiveness and impulsivity in their children at about age 8. Reuters
(10/8)
|
|
 | Inform and Empower
Take action TODAY with a pain advocacy resource that provides inspiration, pain related
news, downloadable materials and tools to inform and empower people
with pain, health care professionals, caregivers and other concerned individuals.
Visit www.IntheFaceofPain.com and download the Handbook for People with
Pain: a Resource Guide, 3rd edition , a resource to help you or a loved on the day-to-day journey facing challenges so often encountered by those who suffer with
pain. |
|
|
| Pharmaceutical News |  |  |
|
- Study: Some drugs remain effective well beyond expiration date
Twelve of 14 compounds analyzed met government requirements for potency up to 40 years after the drugs' expiration dates, according to a study published in the Archives of Internal Medicine. Requiring drugmakers to base expiration dates on long-term stability tests could save consumers money and help alleviate drug shortages, said researcher Lee Cantrell. However, the findings do not mean that all drugs are safe or effective past their expiration dates, Cantrell cautioned. Reuters
(10/8)
- Ranibizumab does not raise adverse ocular events in DME
German researchers found no significant differences after three years in ocular or non-ocular adverse events in diabetic macular edema patients who either had initial as-needed ranibizumab injections or laser surgery. Patients in the ranibizumab-only treatment gained higher mean best-corrected visual acuity compared with those who had ranibizumab plus surgery and surgery-only treatments. The results were presented at the European Association for the Study of Diabetes meeting. MedPage Today (free registration)
(10/7)
- Study: Prostaglandin inhibitors are best against premature birth
A meta-analysis showed that prostaglandin inhibitors, such as Indocin, or indomethacin, and Pfizer's Celebrex, or celecoxib, are best at stopping premature labor. Researchers said prostaglandin inhibitors have an 83% probability of being the best tocolytic treatment in terms of outcome for 48-hour delay of delivery. Meanwhile, calcium channel blockers, such as Cardene, or nicardipine, and nifedipine, have a 6% probability of being the best. MedPage Today (free registration)
(10/10)
| Emerging Trends, Products and Technologies | | |
|
- IOM recommends clearinghouse of EHR reviews, feedback
The Institute of Medicine recommended establishing a central, publicly available database where users of EHRs can share their experiences and reviews. Organizations "will benefit from lessons learned by similar health care organizations about how to improve the performance and safety of their existing systems," wrote the authors of the IOM report. American Medical News (free content)
(10/10)
| Health Policy and Legislative News | | |
|
- Lawmakers call for greater FDA oversight of compounding pharmacies
In response to an outbreak of fungal meningitis linked to steroid injections, Reps. Rosa DeLauro, D-Conn., and Edward Markey, D-Mass., said that they will draft legislation to give the FDA greater authority over compounded drugs. Markey said the agency should be able to prohibit compounding pharmacies from using ingredients that do not have FDA approval, and his legislation would require the businesses to report safety problems to the government. Yahoo/The Associated Press
(10/9)
| AANP News | | |
|
-
AANP's Million Hearts Initiative™ featured in JAANP this month
Two articles featuring the Million Hearts™ initiative are available in the October JAANP. Read the editorial by Dr. Leslie L. Davis and Dr. Janet S. Wright: The Million Hearts™ Initiative: How nurse practitioners can help lead. Also in this issue is an article by Dr. Michelle Edwards that provides a clinical review of novel risk factors for heart disease in women (The enigma of heart disease in women: New insights may precipitate diagnosis and improve patient outcomes).
-
AANP and ACNP breaking news!
The boards of directors of the AANP and the American College of Nurse Practitioners have approved the terms of the agreement for merging the two organizations, and we are thrilled to be able to share this news with you. Pending approval by AANP membership, this consolidation has the ability to further empower the NP community as we continue to shape and direct policy and legislative priorities, and operate from a position of greater strength, unity and visibility. More information is available to members.
| SmartQuote | | |
|
 | Action may not always bring happiness; but there is no happiness without action."
--Benjamin Disraeli,
British politician
|
| |
| Advertise |
| Account Director:
Aaron Kern (202) 407-7866
|
|
|
| |
|
Read more at SmartBrief.com |
|
A powerful website for SmartBrief readers including:
|
|
|
|
| |
| |
| | Recent AANP SmartBrief Issues:
- Wednesday, October 10, 2012
- Tuesday, October 09, 2012
- Monday, October 08, 2012
- Friday, October 05, 2012
- Thursday, October 04, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | |
| |
|
| © 1999-2012 SmartBrief, Inc.® Legal Information |
|
